1 CD38 Monoclonal Antibodies Market Overview 1.1 Product Overview and Scope of CD38 Monoclonal Antibodies 1.2 Classification of CD38 Monoclonal Antibodies by Type 1.2.1 Global CD38 Monoclonal Antibodies Revenue by Type: 2015 VS 2019 VS 2025 1.2.2 Global CD38 Monoclonal Antibodies Revenue Market Share by Type in 2019 1.2.3 Daratumumab 1.2.4 Isatuximab 1.3 Global CD38 Monoclonal Antibodies Market by Application 1.3.1 Overview: Global CD38 Monoclonal Antibodies Revenue by Application: 2015 VS 2019 VS 2025 1.3.2 Pharmacy 1.3.3 Laboratory Use 1.4 Global CD38 Monoclonal Antibodies Market by Regions 1.4.1 Global CD38 Monoclonal Antibodies Market Size by Regions: 2015 VS 2019 VS 2025 1.4.2 Global Market Size of CD38 Monoclonal Antibodies (2015-2025) 1.4.3 North America (USA, Canada and Mexico) CD38 Monoclonal Antibodies Status and Prospect (2015-2025) 1.4.4 Europe (Germany, France, UK, Russia and Italy) CD38 Monoclonal Antibodies Status and Prospect (2015-2025) 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) CD38 Monoclonal Antibodies Status and Prospect (2015-2025) 1.4.6 South America (Brazil, Argentina, Colombia) CD38 Monoclonal Antibodies Status and Prospect (2015-2025) 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) CD38 Monoclonal Antibodies Status and Prospect (2015-2025) 2 Company Profiles 2.1 Johnson & Johnson 2.1.1 Johnson & Johnson Details 2.1.2 Johnson & Johnson Major Business 2.1.3 Johnson & Johnson SWOT Analysis 2.1.4 Johnson & Johnson Product and Services 2.1.5 Johnson & Johnson CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019) 2.2 Carbosynth 2.2.1 Carbosynth Details 2.2.2 Carbosynth Major Business 2.2.3 Carbosynth SWOT Analysis 2.2.4 Carbosynth Product and Services 2.2.5 Carbosynth CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019) 2.3 Sanofi 2.3.1 Sanofi Details 2.3.2 Sanofi Major Business 2.3.3 Sanofi SWOT Analysis 2.3.4 Sanofi Product and Services 2.3.5 Sanofi CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019) 2.4 Janssen Biotech 2.4.1 Janssen Biotech Details 2.4.2 Janssen Biotech Major Business 2.4.3 Janssen Biotech SWOT Analysis 2.4.4 Janssen Biotech Product and Services 2.4.5 Janssen Biotech CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019) 2.5 BOC Sciences 2.5.1 BOC Sciences Details 2.5.2 BOC Sciences Major Business 2.5.3 BOC Sciences SWOT Analysis 2.5.4 BOC Sciences Product and Services 2.5.5 BOC Sciences CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019) 2.6 Creative Biolabs 2.6.1 Creative Biolabs Details 2.6.2 Creative Biolabs Major Business 2.6.3 Creative Biolabs Product and Services 2.6.4 Creative Biolabs CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019) 3 Market Competition, by Players 3.1 Global CD38 Monoclonal Antibodies Revenue and Share by Players (2015-2020) 3.2 Market Concentration Rate 3.2.1 Top 5 CD38 Monoclonal Antibodies Players Market Share 3.2.2 Top 10 CD38 Monoclonal Antibodies Players Market Share 3.3 Market Competition Trend 4 Market Size by Regions 4.1 Global CD38 Monoclonal Antibodies Revenue and Market Share by Regions 4.2 North America CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 4.3 Europe CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 4.4 Asia-Pacific CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 4.5 South America CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 4.6 Middle East & Africa CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 5 North America CD38 Monoclonal Antibodies Revenue by Countries 5.1 North America CD38 Monoclonal Antibodies Revenue by Countries (2015-2020) 5.2 USA CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 5.3 Canada CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 5.4 Mexico CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 6 Europe CD38 Monoclonal Antibodies Revenue by Countries 6.1 Europe CD38 Monoclonal Antibodies Revenue by Countries (2015-2020) 6.2 Germany CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 6.3 UK CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 6.4 France CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 6.5 Russia CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 6.6 Italy CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 7 Asia-Pacific CD38 Monoclonal Antibodies Revenue by Countries 7.1 Asia-Pacific CD38 Monoclonal Antibodies Revenue by Countries (2015-2020) 7.2 China CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 7.3 Japan CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 7.4 Korea CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 7.5 India CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 7.6 Southeast Asia CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 8 South America CD38 Monoclonal Antibodies Revenue by Countries 8.1 South America CD38 Monoclonal Antibodies Revenue by Countries (2015-2020) 8.2 Brazil CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 8.3 Argentina CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 9 Middle East & Africa Revenue CD38 Monoclonal Antibodies by Countries 9.1 Middle East & Africa CD38 Monoclonal Antibodies Revenue by Countries (2015-2020) 9.2 Saudi Arabia CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 9.3 UAE CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 9.4 Egypt CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 9.5 South Africa CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) 10 Market Size Segment by Type 10.1 Global CD38 Monoclonal Antibodies Revenue and Market Share by Type (2015-2020) 10.2 Global CD38 Monoclonal Antibodies Market Forecast by Type (2019-2024) 10.3 Daratumumab Revenue Growth Rate (2015-2025) 10.4 Isatuximab Revenue Growth Rate (2015-2025) 11 Global CD38 Monoclonal Antibodies Market Segment by Application 11.1 Global CD38 Monoclonal Antibodies Revenue Market Share by Application (2015-2020) 11.2 CD38 Monoclonal Antibodies Market Forecast by Application (2019-2024) 11.3 Pharmacy Revenue Growth (2015-2020) 11.4 Laboratory Use Revenue Growth (2015-2020) 12 Global CD38 Monoclonal Antibodies Market Size Forecast (2021-2025) 12.1 Global CD38 Monoclonal Antibodies Market Size Forecast (2021-2025) 12.2 Global CD38 Monoclonal Antibodies Market Forecast by Regions (2021-2025) 12.3 North America CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025) 12.4 Europe CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025) 12.5 Asia-Pacific CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025) 12.6 South America CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025) 12.7 Middle East & Africa CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source 14.3 Disclaimer 14.4 About US

List of Tables Table 1. Global CD38 Monoclonal Antibodies Revenue (USD Million) by Type: 2015 VS 2019 VS 2025 Table 2. Breakdown of CD38 Monoclonal Antibodies by Company Type (Tier 1, Tier 2 and Tier 3) Table 3. Global CD38 Monoclonal Antibodies Revenue (USD Million) by Application: 2015 VS 2019 VS 2025 Table 4. Global Market CD38 Monoclonal Antibodies Revenue (Million USD) Comparison by Regions 2015-2025 Table 5. Global CD38 Monoclonal Antibodies Market Size and Growth Estimation in Various Scenarios in 2020 Table 6. Johnson & Johnson Corporate Information, Location and Competitors Table 7. Johnson & Johnson CD38 Monoclonal Antibodies Major Business Table 8. Johnson & Johnson CD38 Monoclonal Antibodies Total Revenue (USD Million) (2017-2018) Table 9. Johnson & Johnson SWOT Analysis Table 10. Johnson & Johnson CD38 Monoclonal Antibodies Product and Solutions Table 11. Johnson & Johnson CD38 Monoclonal Antibodies Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 12. Carbosynth Corporate Information, Location and Competitors Table 13. Carbosynth CD38 Monoclonal Antibodies Major Business Table 14. Carbosynth CD38 Monoclonal Antibodies Total Revenue (USD Million) (2018-2019) Table 15. Carbosynth SWOT Analysis Table 16. Carbosynth CD38 Monoclonal Antibodies Product and Solutions Table 17. Carbosynth CD38 Monoclonal Antibodies Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 18. Sanofi Corporate Information, Location and Competitors Table 19. Sanofi CD38 Monoclonal Antibodies Major Business Table 20. Sanofi CD38 Monoclonal Antibodies Total Revenue (USD Million) (2017-2018) Table 21. Sanofi SWOT Analysis Table 22. Sanofi CD38 Monoclonal Antibodies Product and Solutions Table 23. Sanofi CD38 Monoclonal Antibodies Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 24. Janssen Biotech Corporate Information, Location and Competitors Table 25. Janssen Biotech CD38 Monoclonal Antibodies Major Business Table 26. Janssen Biotech CD38 Monoclonal Antibodies Total Revenue (USD Million) (2017-2018) Table 27. Janssen Biotech SWOT Analysis Table 28. Janssen Biotech CD38 Monoclonal Antibodies Product and Solutions Table 29. Janssen Biotech CD38 Monoclonal Antibodies Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 30. BOC Sciences Corporate Information, Location and Competitors Table 31. BOC Sciences CD38 Monoclonal Antibodies Major Business Table 32. BOC Sciences CD38 Monoclonal Antibodies Total Revenue (USD Million) (2017-2018) Table 33. BOC Sciences SWOT Analysis Table 34. BOC Sciences CD38 Monoclonal Antibodies Product and Solutions Table 35. BOC Sciences CD38 Monoclonal Antibodies Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 36. Creative Biolabs Corporate Information, Location and Competitors Table 37. Creative Biolabs CD38 Monoclonal Antibodies Major Business Table 38. Creative Biolabs CD38 Monoclonal Antibodies Total Revenue (USD Million) (2017-2018) Table 39. Creative Biolabs SWOT Analysis Table 40. Creative Biolabs CD38 Monoclonal Antibodies Product and Solutions Table 41. Creative Biolabs CD38 Monoclonal Antibodies Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 42. Global CD38 Monoclonal Antibodies Revenue (Million USD) by Players (2015-2020) Table 43. Global CD38 Monoclonal Antibodies Revenue Share by Players (2015-2020) Table 44. Global CD38 Monoclonal Antibodies Revenue (Million USD) by Regions (2015-2020) Table 45. Global CD38 Monoclonal Antibodies Revenue Market Share by Regions (2015-2020) Table 46. North America CD38 Monoclonal Antibodies Revenue by Countries (2015-2020) Table 47. North America CD38 Monoclonal Antibodies Revenue Market Share by Countries (2015-2020) Table 48. Europe CD38 Monoclonal Antibodies Revenue (Million USD) by Countries (2015-2020) Table 49. Asia-Pacific CD38 Monoclonal Antibodies Revenue (Million USD) by Countries (2015-2020) Table 50. South America CD38 Monoclonal Antibodies Revenue by Countries (2015-2020) Table 51. South America CD38 Monoclonal Antibodies Revenue Market Share by Countries (2015-2020) Table 52. Middle East and Africa CD38 Monoclonal Antibodies Revenue (Million USD) by Countries (2015-2020) Table 53. Middle East and Africa CD38 Monoclonal Antibodies Revenue Market Share by Countries (2015-2020) Table 54. Global CD38 Monoclonal Antibodies Revenue (Million USD) by Type (2015-2020) Table 55. Global CD38 Monoclonal Antibodies Revenue Share by Type (2015-2020) Table 56. Global CD38 Monoclonal Antibodies Revenue Forecast by Type (2021-2025) Table 57. Global CD38 Monoclonal Antibodies Revenue by Application (2015-2020) Table 58. Global CD38 Monoclonal Antibodies Revenue Share by Application (2015-2020) Table 59. Global CD38 Monoclonal Antibodies Revenue Forecast by Application (2021-2025) Table 60. Global CD38 Monoclonal Antibodies Revenue (Million USD) Forecast by Regions (2021-2025) List of Figures Figure 1. CD38 Monoclonal Antibodies Picture Figure 2. Global CD38 Monoclonal Antibodies Revenue Market Share by Type in 2019 Figure 3. Daratumumab Picture Figure 4. Isatuximab Picture Figure 5. CD38 Monoclonal Antibodies Revenue Market Share by Application in 2019 Figure 6. Pharmacy Picture Figure 7. Laboratory Use Picture Figure 8. Global CD38 Monoclonal Antibodies Revenue (USD Million) and Growth Rate (2015-2025) Figure 9. North America CD38 Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2015-2025) Figure 10. Europe CD38 Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2015-2025) Figure 11. Asia-Pacific CD38 Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2015-2025) Figure 12. South America CD38 Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2015-2025) Figure 13. Middle East and Africa CD38 Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2015-2025) Figure 14. Global CD38 Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2015-2025) Figure 15. Global CD38 Monoclonal Antibodies Revenue Share by Players in 2019 Figure 16. Global Top 5 Players CD38 Monoclonal Antibodies Revenue Market Share in 2019 Figure 17. Global Top 10 Players CD38 Monoclonal Antibodies Revenue Market Share in 2019 Figure 18. Key Players Market Share Trend Figure 19. Global CD38 Monoclonal Antibodies Revenue (Million USD) and Growth Rate (%) (2015-2020) Figure 20. Global CD38 Monoclonal Antibodies Revenue Market Share by Regions (2015-2020) Figure 21. Global CD38 Monoclonal Antibodies Revenue Market Share by Regions in 2018 Figure 22. North America CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 23. Europe CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 24. Asia-Pacific CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 25. South America CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 26. Middle East and Africa CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 27. North America CD38 Monoclonal Antibodies Revenue Market Share by Countries (2015-2020) Figure 28. North America CD38 Monoclonal Antibodies Revenue Market Share by Countries in 2019 Figure 29. USA CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 30. Canada CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 31. Mexico CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 32. Europe CD38 Monoclonal Antibodies Revenue Market Share by Countries (2015-2020) Figure 33. Europe CD38 Monoclonal Antibodies Revenue Market Share by Countries in 2019 Figure 34. Germany CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 35. UK CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 36. France CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 37. Russia CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 38. Italy CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 39. Asia-Pacific CD38 Monoclonal Antibodies Revenue Market Share by Countries (2015-2020) Figure 40. Asia-Pacific CD38 Monoclonal Antibodies Revenue Market Share by Countries in 2019 Figure 41. China CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 42. Japan CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 43. Korea CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 44. India CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 45. Southeast Asia CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 46. South America CD38 Monoclonal Antibodies Revenue Market Share by Countries (2015-2020) Figure 47. South America CD38 Monoclonal Antibodies Revenue Market Share by Countries in 2019 Figure 48. Brazil CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 49. Argentina CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 50. Middle East and Africa CD38 Monoclonal Antibodies Revenue Market Share by Countries (2015-2020) Figure 51. Middle East and Africa CD38 Monoclonal Antibodies Revenue Market Share by Countries in 2019 Figure 52. Saudi Arabia CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 53. UAE CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 54. Egypt CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 55. South Africa CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020) Figure 56. Global CD38 Monoclonal Antibodies Revenue Share by Type (2015-2020) Figure 57. Global CD38 Monoclonal Antibodies Revenue Share by Type in 2019 Figure 58. Global CD38 Monoclonal Antibodies Market Share Forecast by Type (2021-2025) Figure 59. Global Daratumumab Revenue Growth Rate (2015-2020) Figure 60. Global Isatuximab Revenue Growth Rate (2015-2020) Figure 61. Global CD38 Monoclonal Antibodies Revenue Share by Application (2015-2020) Figure 62. Global CD38 Monoclonal Antibodies Revenue Share by Application in 2019 Figure 63. Global CD38 Monoclonal Antibodies Market Share Forecast by Application (2021-2025) Figure 64. Global Pharmacy Revenue Growth Rate (2015-2020) Figure 65. Global Laboratory Use Revenue Growth Rate (2015-2020) Figure 66. Global CD38 Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2021-2025) Figure 67. Global CD38 Monoclonal Antibodies Revenue (Million USD) Forecast by Regions (2021-2025) Figure 68. Global CD38 Monoclonal Antibodies Revenue Market Share Forecast by Regions (2021-2025) Figure 69. North America CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025) Figure 70. Europe CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025) Figure 71. Asia-Pacific CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025) Figure 72. South America CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025) Figure 73. Middle East and Africa CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025) Figure 74. Sales Channel: Direct Channel vs Indirect Channel

Johnson & Johnson Carbosynth Sanofi Janssen Biotech BOC Sciences Creative Biolabs